Mechanistic	O
and	O
structural	B:C0678594
basis	O
of	O
bioengineered	O
bovine	O
Cathelicidin	O
-	I:C0671062
5	I:C0671062
with	O
optimized	O
therapeutic	O
activity	I:C0556489
Peptide	O
-	O
drug	O
discovery	I:C0920472
using	O
host	O
-	I:C0520990
defense	I:C0520990
peptides	O
becomes	O
promising	O
against	O
antibiotic	O
-	O
resistant	O
pathogens	O
and	O
cancer	O
cells	I:C0334227
.	O

Mechanistic	O
and	O
structural	O
basis	O
of	O
bioengineered	B:C0005539
bovine	O
Cathelicidin	O
-	I:C0671062
5	I:C0671062
with	O
optimized	O
therapeutic	O
activity	I:C0556489
Peptide	O
-	O
drug	O
discovery	I:C0920472
using	O
host	O
-	I:C0520990
defense	I:C0520990
peptides	O
becomes	O
promising	O
against	O
antibiotic	O
-	O
resistant	O
pathogens	O
and	O
cancer	O
cells	I:C0334227
.	O

Mechanistic	O
and	O
structural	O
basis	O
of	O
bioengineered	O
bovine	B:C3667982
Cathelicidin	O
-	I:C0671062
5	I:C0671062
with	O
optimized	O
therapeutic	O
activity	I:C0556489
Peptide	O
-	O
drug	O
discovery	I:C0920472
using	O
host	O
-	I:C0520990
defense	I:C0520990
peptides	O
becomes	O
promising	O
against	O
antibiotic	O
-	O
resistant	O
pathogens	O
and	O
cancer	O
cells	I:C0334227
.	O

Mechanistic	O
and	O
structural	O
basis	O
of	O
bioengineered	O
bovine	O
Cathelicidin	B:C0671062
-	I:C0671062
5	I:C0671062
with	O
optimized	O
therapeutic	O
activity	I:C0556489
Peptide	O
-	O
drug	O
discovery	I:C0920472
using	O
host	O
-	I:C0520990
defense	I:C0520990
peptides	O
becomes	O
promising	O
against	O
antibiotic	O
-	O
resistant	O
pathogens	O
and	O
cancer	O
cells	I:C0334227
.	O

Mechanistic	O
and	O
structural	O
basis	O
of	O
bioengineered	O
bovine	O
Cathelicidin	O
-	I:C0671062
5	I:C0671062
with	O
optimized	O
therapeutic	B:C0556489
activity	I:C0556489
Peptide	O
-	O
drug	O
discovery	I:C0920472
using	O
host	O
-	I:C0520990
defense	I:C0520990
peptides	O
becomes	O
promising	O
against	O
antibiotic	O
-	O
resistant	O
pathogens	O
and	O
cancer	O
cells	I:C0334227
.	O

Mechanistic	O
and	O
structural	O
basis	O
of	O
bioengineered	O
bovine	O
Cathelicidin	O
-	I:C0671062
5	I:C0671062
with	O
optimized	O
therapeutic	O
activity	I:C0556489
Peptide	B:C0030956
-	O
drug	O
discovery	I:C0920472
using	O
host	O
-	I:C0520990
defense	I:C0520990
peptides	O
becomes	O
promising	O
against	O
antibiotic	O
-	O
resistant	O
pathogens	O
and	O
cancer	O
cells	I:C0334227
.	O

Mechanistic	O
and	O
structural	O
basis	O
of	O
bioengineered	O
bovine	O
Cathelicidin	O
-	I:C0671062
5	I:C0671062
with	O
optimized	O
therapeutic	O
activity	I:C0556489
Peptide	O
-	O
drug	B:C0920472
discovery	I:C0920472
using	O
host	O
-	I:C0520990
defense	I:C0520990
peptides	O
becomes	O
promising	O
against	O
antibiotic	O
-	O
resistant	O
pathogens	O
and	O
cancer	O
cells	I:C0334227
.	O

Mechanistic	O
and	O
structural	O
basis	O
of	O
bioengineered	O
bovine	O
Cathelicidin	O
-	I:C0671062
5	I:C0671062
with	O
optimized	O
therapeutic	O
activity	I:C0556489
Peptide	O
-	O
drug	O
discovery	I:C0920472
using	O
host	B:C0520990
-	I:C0520990
defense	I:C0520990
peptides	O
becomes	O
promising	O
against	O
antibiotic	O
-	O
resistant	O
pathogens	O
and	O
cancer	O
cells	I:C0334227
.	O

Mechanistic	O
and	O
structural	O
basis	O
of	O
bioengineered	O
bovine	O
Cathelicidin	O
-	I:C0671062
5	I:C0671062
with	O
optimized	O
therapeutic	O
activity	I:C0556489
Peptide	O
-	O
drug	O
discovery	I:C0920472
using	O
host	O
-	I:C0520990
defense	I:C0520990
peptides	B:C0030956
becomes	O
promising	O
against	O
antibiotic	O
-	O
resistant	O
pathogens	O
and	O
cancer	O
cells	I:C0334227
.	O

Mechanistic	O
and	O
structural	O
basis	O
of	O
bioengineered	O
bovine	O
Cathelicidin	O
-	I:C0671062
5	I:C0671062
with	O
optimized	O
therapeutic	O
activity	I:C0556489
Peptide	O
-	O
drug	O
discovery	I:C0920472
using	O
host	O
-	I:C0520990
defense	I:C0520990
peptides	O
becomes	O
promising	O
against	O
antibiotic	B:C0003232
-	O
resistant	O
pathogens	O
and	O
cancer	O
cells	I:C0334227
.	O

Mechanistic	O
and	O
structural	O
basis	O
of	O
bioengineered	O
bovine	O
Cathelicidin	O
-	I:C0671062
5	I:C0671062
with	O
optimized	O
therapeutic	O
activity	I:C0556489
Peptide	O
-	O
drug	O
discovery	I:C0920472
using	O
host	O
-	I:C0520990
defense	I:C0520990
peptides	O
becomes	O
promising	O
against	O
antibiotic	O
-	O
resistant	O
pathogens	O
and	O
cancer	B:C0334227
cells	I:C0334227
.	O

Here	O
,	O
we	O
customized	O
the	O
therapeutic	B:C0556489
activity	I:C0556489
of	O
bovine	O
cathelicidin	O
-	I:C0671062
5	I:C0671062
targeting	O
to	O
bacteria	O
,	O
protozoa	O
,	O
and	O
tumor	O
cells	I:C0597032
.	O

Here	O
,	O
we	O
customized	O
the	O
therapeutic	O
activity	I:C0556489
of	O
bovine	B:C3667982
cathelicidin	O
-	I:C0671062
5	I:C0671062
targeting	O
to	O
bacteria	O
,	O
protozoa	O
,	O
and	O
tumor	O
cells	I:C0597032
.	O

Here	O
,	O
we	O
customized	O
the	O
therapeutic	O
activity	I:C0556489
of	O
bovine	O
cathelicidin	B:C0671062
-	I:C0671062
5	I:C0671062
targeting	O
to	O
bacteria	O
,	O
protozoa	O
,	O
and	O
tumor	O
cells	I:C0597032
.	O

Here	O
,	O
we	O
customized	O
the	O
therapeutic	O
activity	I:C0556489
of	O
bovine	O
cathelicidin	O
-	I:C0671062
5	I:C0671062
targeting	O
to	O
bacteria	B:C0004611
,	O
protozoa	O
,	O
and	O
tumor	O
cells	I:C0597032
.	O

Here	O
,	O
we	O
customized	O
the	O
therapeutic	O
activity	I:C0556489
of	O
bovine	O
cathelicidin	O
-	I:C0671062
5	I:C0671062
targeting	O
to	O
bacteria	O
,	O
protozoa	B:C0033739
,	O
and	O
tumor	O
cells	I:C0597032
.	O

Here	O
,	O
we	O
customized	O
the	O
therapeutic	O
activity	I:C0556489
of	O
bovine	O
cathelicidin	O
-	I:C0671062
5	I:C0671062
targeting	O
to	O
bacteria	O
,	O
protozoa	O
,	O
and	O
tumor	B:C0597032
cells	I:C0597032
.	O

The	O
membrane	B:C0596901
dependent	O
conformational	O
adaptability	O
and	O
plasticity	O
of	O
cathelicidin	O
-	I:C0671062
5	I:C0671062
is	O
revealed	O
by	O
biophysical	O
analysis	O
and	O
atomistic	O
simulations	I:C0679083
over	O
200	O
μs	O
in	O
thymocytes	O
,	O
leukemia	O
,	O
and	O
E.	O
coli	I:C0014834
cell	O
-	I:C0007603
membranes	I:C0007603
.	O

The	O
membrane	O
dependent	O
conformational	B:C0026377
adaptability	O
and	O
plasticity	O
of	O
cathelicidin	O
-	I:C0671062
5	I:C0671062
is	O
revealed	O
by	O
biophysical	O
analysis	O
and	O
atomistic	O
simulations	I:C0679083
over	O
200	O
μs	O
in	O
thymocytes	O
,	O
leukemia	O
,	O
and	O
E.	O
coli	I:C0014834
cell	O
-	I:C0007603
membranes	I:C0007603
.	O

The	O
membrane	O
dependent	O
conformational	O
adaptability	O
and	O
plasticity	O
of	O
cathelicidin	B:C0671062
-	I:C0671062
5	I:C0671062
is	O
revealed	O
by	O
biophysical	O
analysis	O
and	O
atomistic	O
simulations	I:C0679083
over	O
200	O
μs	O
in	O
thymocytes	O
,	O
leukemia	O
,	O
and	O
E.	O
coli	I:C0014834
cell	O
-	I:C0007603
membranes	I:C0007603
.	O

The	O
membrane	O
dependent	O
conformational	O
adaptability	O
and	O
plasticity	O
of	O
cathelicidin	O
-	I:C0671062
5	I:C0671062
is	O
revealed	O
by	O
biophysical	B:C0005553
analysis	O
and	O
atomistic	O
simulations	I:C0679083
over	O
200	O
μs	O
in	O
thymocytes	O
,	O
leukemia	O
,	O
and	O
E.	O
coli	I:C0014834
cell	O
-	I:C0007603
membranes	I:C0007603
.	O

The	O
membrane	O
dependent	O
conformational	O
adaptability	O
and	O
plasticity	O
of	O
cathelicidin	O
-	I:C0671062
5	I:C0671062
is	O
revealed	O
by	O
biophysical	O
analysis	B:C0936012
and	O
atomistic	O
simulations	I:C0679083
over	O
200	O
μs	O
in	O
thymocytes	O
,	O
leukemia	O
,	O
and	O
E.	O
coli	I:C0014834
cell	O
-	I:C0007603
membranes	I:C0007603
.	O

The	O
membrane	O
dependent	O
conformational	O
adaptability	O
and	O
plasticity	O
of	O
cathelicidin	O
-	I:C0671062
5	I:C0671062
is	O
revealed	O
by	O
biophysical	O
analysis	O
and	O
atomistic	B:C0679083
simulations	I:C0679083
over	O
200	O
μs	O
in	O
thymocytes	O
,	O
leukemia	O
,	O
and	O
E.	O
coli	I:C0014834
cell	O
-	I:C0007603
membranes	I:C0007603
.	O

The	O
membrane	O
dependent	O
conformational	O
adaptability	O
and	O
plasticity	O
of	O
cathelicidin	O
-	I:C0671062
5	I:C0671062
is	O
revealed	O
by	O
biophysical	O
analysis	O
and	O
atomistic	O
simulations	I:C0679083
over	O
200	O
μs	O
in	O
thymocytes	B:C0814999
,	O
leukemia	O
,	O
and	O
E.	O
coli	I:C0014834
cell	O
-	I:C0007603
membranes	I:C0007603
.	O

The	O
membrane	O
dependent	O
conformational	O
adaptability	O
and	O
plasticity	O
of	O
cathelicidin	O
-	I:C0671062
5	I:C0671062
is	O
revealed	O
by	O
biophysical	O
analysis	O
and	O
atomistic	O
simulations	I:C0679083
over	O
200	O
μs	O
in	O
thymocytes	O
,	O
leukemia	B:C0023418
,	O
and	O
E.	O
coli	I:C0014834
cell	O
-	I:C0007603
membranes	I:C0007603
.	O

The	O
membrane	O
dependent	O
conformational	O
adaptability	O
and	O
plasticity	O
of	O
cathelicidin	O
-	I:C0671062
5	I:C0671062
is	O
revealed	O
by	O
biophysical	O
analysis	O
and	O
atomistic	O
simulations	I:C0679083
over	O
200	O
μs	O
in	O
thymocytes	O
,	O
leukemia	O
,	O
and	O
E.	B:C0014834
coli	I:C0014834
cell	O
-	I:C0007603
membranes	I:C0007603
.	O

The	O
membrane	O
dependent	O
conformational	O
adaptability	O
and	O
plasticity	O
of	O
cathelicidin	O
-	I:C0671062
5	I:C0671062
is	O
revealed	O
by	O
biophysical	O
analysis	O
and	O
atomistic	O
simulations	I:C0679083
over	O
200	O
μs	O
in	O
thymocytes	O
,	O
leukemia	O
,	O
and	O
E.	O
coli	I:C0014834
cell	B:C0007603
-	I:C0007603
membranes	I:C0007603
.	O

Our	O
understanding	O
of	O
energy	O
-	O
dependent	O
cathelicidin	B:C0671062
-	I:C0671062
5	I:C0671062
intrusion	O
in	O
heterogeneous	O
membranes	O
aided	O
in	O
designing	O
novel	O
loss	O
/	I:C0243095
gain	I:C0243095
-	I:C0243095
of	I:C0243095
-	I:C0243095
function	I:C0243095
analogues	O
.	O

Our	O
understanding	O
of	O
energy	O
-	O
dependent	O
cathelicidin	O
-	I:C0671062
5	I:C0671062
intrusion	B:C0087111
in	O
heterogeneous	O
membranes	O
aided	O
in	O
designing	O
novel	O
loss	O
/	I:C0243095
gain	I:C0243095
-	I:C0243095
of	I:C0243095
-	I:C0243095
function	I:C0243095
analogues	O
.	O

Our	O
understanding	O
of	O
energy	O
-	O
dependent	O
cathelicidin	O
-	I:C0671062
5	I:C0671062
intrusion	O
in	O
heterogeneous	O
membranes	B:C0007603
aided	O
in	O
designing	O
novel	O
loss	O
/	I:C0243095
gain	I:C0243095
-	I:C0243095
of	I:C0243095
-	I:C0243095
function	I:C0243095
analogues	O
.	O

Our	O
understanding	O
of	O
energy	O
-	O
dependent	O
cathelicidin	O
-	I:C0671062
5	I:C0671062
intrusion	O
in	O
heterogeneous	O
membranes	O
aided	O
in	O
designing	O
novel	O
loss	B:C0243095
/	I:C0243095
gain	I:C0243095
-	I:C0243095
of	I:C0243095
-	I:C0243095
function	I:C0243095
analogues	O
.	O

Our	O
understanding	O
of	O
energy	O
-	O
dependent	O
cathelicidin	O
-	I:C0671062
5	I:C0671062
intrusion	O
in	O
heterogeneous	O
membranes	O
aided	O
in	O
designing	O
novel	O
loss	O
/	I:C0243095
gain	I:C0243095
-	I:C0243095
of	I:C0243095
-	I:C0243095
function	I:C0243095
analogues	B:C0002776
.	O

In	O
vitro	O
findings	O
identified	O
leucine	B:C0079686
-	I:C0079686
zipper	I:C0079686
to	O
phenylalanine	O
substitution	O
in	O
cathelicidin	O
-	I:C0671062
5	I:C0671062
(	O
1	O
-	O
18	O
)	O
significantly	O
enhance	O
the	O
antimicrobial	O
and	O
anticancer	O
activity	I:C0243095
with	O
trivial	O
hemolytic	O
activity	I:C2945560
.	O

In	O
vitro	O
findings	O
identified	O
leucine	O
-	I:C0079686
zipper	I:C0079686
to	O
phenylalanine	B:C0031453
substitution	O
in	O
cathelicidin	O
-	I:C0671062
5	I:C0671062
(	O
1	O
-	O
18	O
)	O
significantly	O
enhance	O
the	O
antimicrobial	O
and	O
anticancer	O
activity	I:C0243095
with	O
trivial	O
hemolytic	O
activity	I:C2945560
.	O

In	O
vitro	O
findings	O
identified	O
leucine	O
-	I:C0079686
zipper	I:C0079686
to	O
phenylalanine	O
substitution	O
in	O
cathelicidin	B:C0671062
-	I:C0671062
5	I:C0671062
(	O
1	O
-	O
18	O
)	O
significantly	O
enhance	O
the	O
antimicrobial	O
and	O
anticancer	O
activity	I:C0243095
with	O
trivial	O
hemolytic	O
activity	I:C2945560
.	O

In	O
vitro	O
findings	O
identified	O
leucine	O
-	I:C0079686
zipper	I:C0079686
to	O
phenylalanine	O
substitution	O
in	O
cathelicidin	O
-	I:C0671062
5	I:C0671062
(	O
1	O
-	O
18	O
)	O
significantly	O
enhance	O
the	O
antimicrobial	B:C1321418
and	O
anticancer	O
activity	I:C0243095
with	O
trivial	O
hemolytic	O
activity	I:C2945560
.	O

In	O
vitro	O
findings	O
identified	O
leucine	O
-	I:C0079686
zipper	I:C0079686
to	O
phenylalanine	O
substitution	O
in	O
cathelicidin	O
-	I:C0671062
5	I:C0671062
(	O
1	O
-	O
18	O
)	O
significantly	O
enhance	O
the	O
antimicrobial	O
and	O
anticancer	B:C0243095
activity	I:C0243095
with	O
trivial	O
hemolytic	O
activity	I:C2945560
.	O

In	O
vitro	O
findings	O
identified	O
leucine	O
-	I:C0079686
zipper	I:C0079686
to	O
phenylalanine	O
substitution	O
in	O
cathelicidin	O
-	I:C0671062
5	I:C0671062
(	O
1	O
-	O
18	O
)	O
significantly	O
enhance	O
the	O
antimicrobial	O
and	O
anticancer	O
activity	I:C0243095
with	O
trivial	O
hemolytic	B:C2945560
activity	I:C2945560
.	O

Targeted	B:C0596988
mutants	I:C0596988
of	O
cathelicidin	O
-	I:C0671062
5	I:C0671062
at	O
kink	O
region	O
and	O
N	O
-	I:C1514568
terminal	I:C1514568
truncation	I:C1514568
revealed	O
loss	O
-	I:C0243095
of	I:C0243095
-	I:C0243095
function	I:C0243095
.	O

Targeted	O
mutants	I:C0596988
of	O
cathelicidin	B:C0671062
-	I:C0671062
5	I:C0671062
at	O
kink	O
region	O
and	O
N	O
-	I:C1514568
terminal	I:C1514568
truncation	I:C1514568
revealed	O
loss	O
-	I:C0243095
of	I:C0243095
-	I:C0243095
function	I:C0243095
.	O

Targeted	O
mutants	I:C0596988
of	O
cathelicidin	O
-	I:C0671062
5	I:C0671062
at	O
kink	O
region	O
and	O
N	B:C1514568
-	I:C1514568
terminal	I:C1514568
truncation	I:C1514568
revealed	O
loss	O
-	I:C0243095
of	I:C0243095
-	I:C0243095
function	I:C0243095
.	O

Targeted	O
mutants	I:C0596988
of	O
cathelicidin	O
-	I:C0671062
5	I:C0671062
at	O
kink	O
region	O
and	O
N	O
-	I:C1514568
terminal	I:C1514568
truncation	I:C1514568
revealed	O
loss	B:C0243095
-	I:C0243095
of	I:C0243095
-	I:C0243095
function	I:C0243095
.	O

We	O
ensured	O
the	O
existence	O
of	O
a	O
bimodal	O
mechanism	O
of	O
peptide	B:C0030956
action	O
(	O
membranolytic	O
and	O
non-membranolytic	O
)	O
in	O
vitro	O
.	O

We	O
ensured	O
the	O
existence	O
of	O
a	O
bimodal	O
mechanism	O
of	O
peptide	O
action	O
(	O
membranolytic	B:C2825141
and	O
non-membranolytic	O
)	O
in	O
vitro	O
.	O

We	O
ensured	O
the	O
existence	O
of	O
a	O
bimodal	O
mechanism	O
of	O
peptide	O
action	O
(	O
membranolytic	O
and	O
non-membranolytic	B:C2825141
)	O
in	O
vitro	O
.	O

The	O
melanoma	B:C0025202
mouse	O
model	I:C2986594
in	O
vivo	O
study	O
further	O
supports	O
the	O
in	O
vitro	O
findings	O
.	O

The	O
melanoma	O
mouse	B:C2986594
model	I:C2986594
in	O
vivo	O
study	O
further	O
supports	O
the	O
in	O
vitro	O
findings	O
.	O

This	O
is	O
the	O
first	O
structural	O
report	O
on	O
cathelicidin	B:C0671062
-	I:C0671062
5	I:C0671062
and	O
our	O
findings	O
revealed	O
potent	O
therapeutic	O
application	I:C0278296
of	O
designed	O
cathelicidin	O
-	I:C0671062
5	I:C0671062
analogues	O
.	O

This	O
is	O
the	O
first	O
structural	O
report	O
on	O
cathelicidin	O
-	I:C0671062
5	I:C0671062
and	O
our	O
findings	O
revealed	O
potent	O
therapeutic	B:C0278296
application	I:C0278296
of	O
designed	O
cathelicidin	O
-	I:C0671062
5	I:C0671062
analogues	O
.	O

This	O
is	O
the	O
first	O
structural	O
report	O
on	O
cathelicidin	O
-	I:C0671062
5	I:C0671062
and	O
our	O
findings	O
revealed	O
potent	O
therapeutic	O
application	I:C0278296
of	O
designed	O
cathelicidin	B:C0671062
-	I:C0671062
5	I:C0671062
analogues	O
.	O

This	O
is	O
the	O
first	O
structural	O
report	O
on	O
cathelicidin	O
-	I:C0671062
5	I:C0671062
and	O
our	O
findings	O
revealed	O
potent	O
therapeutic	O
application	I:C0278296
of	O
designed	O
cathelicidin	O
-	I:C0671062
5	I:C0671062
analogues	B:C0002776
.	O

